Walking Speed Drives the Prognosis of Older Adults with Cardiovascular and Neuropsychiatric Multimorbidity - 06/11/19
, Debora Rizzuto, PhD a, Amaia Calderón-Larrañaga, MpH, PhD a, Graziano Onder, MD, PhD b, Anna-Karin Welmer, PhD a, c, Chengxuan Qiu, PhD a, Roberto Bernabei, MD b, Alessandra Marengoni, MD, PhD a, d, Laura Fratiglioni, MD, PhD a, eAbstract |
Background |
We investigated the impact of multiple cardiovascular and neuropsychiatric diseases on all-cause and cause-specific mortality in older adults, considering their functional status.
Methods |
This cohort study included 3241 participants (aged ≥60 years) in the Swedish National study of Aging and Care in Kungsholmen (SNAC-K). Number of cardiovascular and neuropsychiatric diseases was categorized as 0, 1, or ≥2. Functional impairment was defined as walking speed of <0.8m/s. Death certificates provided information on 3- and 5-year mortality. Hazard ratios (HR) were derived from Cox models (all-cause mortality) and Fine-Gray competing risk models (cardiovascular and non-cardiovascular mortality).
Results |
After 3 years, compared with participants with preserved walking speed and without either cardiovascular or neuropsychiatric diseases, the multivariable-adjusted HR (95% confidence interval) of all-cause mortality for people with functional impairment in combination with 0, 1, and ≥2 cardiovascular diseases were 1.88 (1.29-2.74), 3.85 (2.60-5.70), and 5.18 (3.45-7.78), respectively. The corresponding figures for people with 0, 1, and ≥2 neuropsychiatric diseases were, respectively, 2.88 (2.03-4.08), 3.36 (2.31-4.89), and 3.68 (2.43-5.59). Among people with ≥2 cardiovascular or ≥2 neuropsychiatric diseases, those with functional impairment had an excess risk for 3-year all-cause mortality of 18/100 person-years and 17/100 person-years, respectively, than those without functional impairment. At 5 years, the association between the number of cardiovascular diseases and mortality resulted independent of functional impairment.
Conclusions |
Functional impairment magnifies the effect of cardiovascular and neuropsychiatric multimorbidity on mortality among older adults. Walking speed appears to be a simple clinical marker for the prognosis of these two patterns of multimorbidity.
Le texte complet de cet article est disponible en PDF.Keywords : Chronic disease, Frailty, Functional decline, Multimorbidity, Personalized medicine, Population-based study, Walking speed
Plan
| Funding: This work was supported by the funders of the Swedish National study on Aging and Care (SNAC): the Ministry of Health and Social Affairs, Sweden; the participating County Councils and Municipalities; and the Swedish Research Council. Specific grants were received from The Swedish Research Council for Medicine (VR; 521-2013-8676; 2017-06088; 2016-00981); the Swedish Research Council for Health, Working Life and Welfare (Forte; 2016-07175; 2017-01764); the Catholic University of Rome; The Italian Ministry of Health (PE-2016-02364885); Lindhés Advokatbyrå AB (LA2016-0450); Stiftelsen för Gamla Tjänarinnor (2016-00373); Stonhes Stiftelse (4-3066/2016); and the Ermenegildo Zegna Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
|
| Conflict of Interest: None |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
|
| Data Sharing: Data are from the SNAC-K project, a population-based study on aging and dementia (www.snac-k.se/). Access to these original data is available to the research community upon approval by the SNAC-K data management and maintenance committee. Applications for accessing these data can be submitted to Maria Wahlberg (Maria.Wahlberg@ki.se) at the Aging Research Center, Karolinska Institutet. |
Vol 132 - N° 10
P. 1207 - octobre 2019 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
